Back to search
FDAFDA · Food and drugs·Recall number F-0540-2021

BTREX PLUS, Dietary Supplement 2 Caplets, UPC 05380930802 (Physician Samples)

Published May 26, 2021 · Recall initiated: July 13, 2020

Summary

FDA records food Class III recall F-0540-2021, published May 26, 2021 and initiated July 13, 2020. Recalling firm: Lopez Gonzalez Santana Corporation; Status: Terminated; Reported quantity: lots #32179  1405 and Lot #33278 - 0.; Lot: Lot# 32179, Exp. 9/2022 Lot# 33278, Exp. 12/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Presence of damaged tablets

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lopez Gonzalez Santana Corporation
Distributor
Domestic distribution only-PR
Lot
Lot# 32179, Exp. 9/2022 Lot# 33278, Exp. 12/2022
Risk classification
Class III
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was BTREX PLUS, Dietary Supplement 2 Caplets, UPC 05380930802 (Physician Samples) recalled?

Yes. FDA published recall F-0540-2021 on May 26, 2021. Reported hazard: CGMP Deviations: Presence of damaged tablets

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail